258 related articles for article (PubMed ID: 12707394)
1. Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy.
Zhang G; Kim H; Cai X; López-Guisa JM; Alpers CE; Liu Y; Carmeliet P; Eddy AA
J Am Soc Nephrol; 2003 May; 14(5):1254-71. PubMed ID: 12707394
[TBL] [Abstract][Full Text] [Related]
2. Urokinase receptor modulates cellular and angiogenic responses in obstructive nephropathy.
Zhang G; Kim H; Cai X; Lopez-Guisa JM; Carmeliet P; Eddy AA
J Am Soc Nephrol; 2003 May; 14(5):1234-53. PubMed ID: 12707393
[TBL] [Abstract][Full Text] [Related]
3. Endogenous urokinase lacks antifibrotic activity during progressive renal injury.
Yamaguchi I; Lopez-Guisa JM; Cai X; Collins SJ; Okamura DM; Eddy AA
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F12-9. PubMed ID: 17356128
[TBL] [Abstract][Full Text] [Related]
4. Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice.
Matsuo S; López-Guisa JM; Cai X; Okamura DM; Alpers CE; Bumgarner RE; Peters MA; Zhang G; Eddy AA
Kidney Int; 2005 Jun; 67(6):2221-38. PubMed ID: 15882265
[TBL] [Abstract][Full Text] [Related]
5. Plasmin is not protective in experimental renal interstitial fibrosis.
Edgtton KL; Gow RM; Kelly DJ; Carmeliet P; Kitching AR
Kidney Int; 2004 Jul; 66(1):68-76. PubMed ID: 15200414
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.
Ma LJ; Yang H; Gaspert A; Carlesso G; Barty MM; Davidson JM; Sheppard D; Fogo AB
Am J Pathol; 2003 Oct; 163(4):1261-73. PubMed ID: 14507636
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
[TBL] [Abstract][Full Text] [Related]
8. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction.
Oda T; Jung YO; Kim HS; Cai X; López-Guisa JM; Ikeda Y; Eddy AA
Kidney Int; 2001 Aug; 60(2):587-96. PubMed ID: 11473641
[TBL] [Abstract][Full Text] [Related]
9. TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy.
Kim H; Oda T; López-Guisa J; Wing D; Edwards DR; Soloway PD; Eddy AA
J Am Soc Nephrol; 2001 Apr; 12(4):736-748. PubMed ID: 11274235
[TBL] [Abstract][Full Text] [Related]
10. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
Zhang G; Cai X; López-Guisa JM; Collins SJ; Eddy AA
J Am Soc Nephrol; 2004 Aug; 15(8):2090-102. PubMed ID: 15284295
[TBL] [Abstract][Full Text] [Related]
11. Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease.
López-Guisa JM; Rassa AC; Cai X; Collins SJ; Eddy AA
Am J Physiol Renal Physiol; 2011 May; 300(5):F1244-54. PubMed ID: 21270094
[TBL] [Abstract][Full Text] [Related]
12. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
[TBL] [Abstract][Full Text] [Related]
13. The selective A3AR antagonist LJ-1888 ameliorates UUO-induced tubulointerstitial fibrosis.
Lee J; Hwang I; Lee JH; Lee HW; Jeong LS; Ha H
Am J Pathol; 2013 Nov; 183(5):1488-1497. PubMed ID: 24001475
[TBL] [Abstract][Full Text] [Related]
14. [Regulative effect of Astragalus mongholicus on hepatocyte growth factor and transforming growth factor-beta1 in rats with unilateral ureteral obstruction].
Zuo C; Xie X; Deng Y; Fan J
Wei Sheng Yan Jiu; 2008 Sep; 37(5):566-70. PubMed ID: 19069655
[TBL] [Abstract][Full Text] [Related]
15. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy.
Guo G; Morrissey J; McCracken R; Tolley T; Klahr S
Am J Physiol; 1999 Nov; 277(5):F766-72. PubMed ID: 10564241
[TBL] [Abstract][Full Text] [Related]
16. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy.
Yang J; Liu Y
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F349-57. PubMed ID: 12529273
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of HSP47 in the mouse kidneys with unilateral ureteral obstruction.
Moriyama T; Kawada N; Ando A; Yamauchi A; Horio M; Nagata K; Imai E; Hori M
Kidney Int; 1998 Jul; 54(1):110-9. PubMed ID: 9648069
[TBL] [Abstract][Full Text] [Related]
18. [Role of integrin-linked kinase in renal tubular epithelial-mesenchymal transition and the regulatory effect of urokinase on its expression in mice with obstructive nephropathy].
He F; Yu L; Tong JR; Luo ZM; Zhu QZ; Wang Y; Zhang JL
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):909-13. PubMed ID: 19460706
[TBL] [Abstract][Full Text] [Related]
19. Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-beta.
Wright EJ; McCaffrey TA; Robertson AP; Vaughan ED; Felsen D
Lab Invest; 1996 Feb; 74(2):528-37. PubMed ID: 8780170
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha deficiency accelerates renal tubular interstitial fibrosis in the late stage of ureteral obstruction.
Morimoto Y; Gai Z; Tanishima H; Kawakatsu M; Itoh S; Hatamura I; Muragaki Y
Exp Mol Pathol; 2008 Dec; 85(3):207-13. PubMed ID: 18840428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
